Therapeutics: Fatty acid synthase (FASN; FAS); epidermal growth factor receptor 2 (HER2; EGFR2; ErbB2; neu)

Cancer

INDICATION: Breast cancer

Cell culture and mouse studies identified an inhibitor of FASN activity that

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE